ComputChem Awarded $1,373,997 in SBIR Phase II Funding from the National Institutes of Health
SBIR award will enable ComputChem to create software for better drug design and development November 19, 2021, Baltimore, MD – ComputChem, a technology company building next-generation platform solutions for in silico covalent drug design and lead optimization, today announced it has been awarded a $1,373,997 Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of [...]
